English Spanish Chinese Russian German Japanese Portuguese Hindi Telugu Tamil

Journal international du développement et de la recherche sur les médicaments

  • ISSN: 0975-9344
  • Indice h du journal: 44
  • Note de citation du journal: 59.93
  • Facteur d’impact du journal: 48.80
Indexé dans
  • Genamics JournalSeek
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • CiteFactor
  • Scimago
  • Répertoire d'indexation des revues de recherche (DRJI)
  • OCLC - WorldCat
  • Publions
  • MIAR
  • Commission des bourses universitaires
  • Pub européen
  • Google Scholar
  • SHERPA ROMÉO
  • Laboratoires secrets des moteurs de recherche
  • ResearchGate
Voir plus
Partager cette page

Abstrait

Acute Lung Injury and Sepsis Pharmacology

Ben Morton*

One of the main causes of death in sepsis is acute lung damage (ALI) linked to the condition. As a result, numerous pharmacological and nonpharmacological techniques have been used to slow its progression. Few of these tactics have actually been successful. The epidemiology and pathophysiology of ALI, frequently used pharmacologic and nonpharmacologic treatments, and novel therapeutic modalities that are anticipated to be the subject of future trials are all covered in this article.

Keywords

Acute lung injury; Sepsis; Pharmacology; Immune response; Cytokines; Epidemiology; Anti-inflammatory agents